Viewing StudyNCT00419770



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00419770
Status: COMPLETED
Last Update Posted: 2023-10-16
First Post: 2007-01-05

Brief Title: The Deferasirox-AmBisome Therapy for Mucormycosis DEFEAT Mucor Study
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Organization: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Organization Data

Organization: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Class: OTHER
Study ID: 12842
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Novartis INDUSTRY
Gilead Sciences INDUSTRY
Astellas Pharma Inc INDUSTRY